Last reviewed · How we verify
NCT03934957: HCHS
Hamburg City Health Study - a German Cohort Study
trial in Coronary Heart Disease in 45,000 participants. Currently enrolling.
31 December 2022
Quick facts
| Lead sponsor | Universitätsklinikum Hamburg-Eppendorf |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 45,000 |
| Start date | 8 February 2016 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 December 2028 |
| Sites | 1 location across Germany |
Conditions studied
- Coronary Heart Disease — all drugs for Coronary Heart Disease →
- Stroke — all drugs for Stroke →
- Dementia — all drugs for Dementia →
- Cancer — all drugs for Cancer →
Sponsor
Universitätsklinikum Hamburg-Eppendorf — full company profile →
Who can join
Adults 45 to 74, any sex, with Coronary Heart Disease or Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Hamburg City Health Study (HCHS) is a large, prospective, long-term, population-based cohort study and a unique research platform and network to obtain substantial knowledge about several risk and prognostic factors in major chronic diseases.
Publications & conference data
8 peer-reviewed publications reference this trial (live from Europe PMC):
-
Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme.
Petersen EL, Goßling A, Adam G, Aepfelbacher M, et al · · 2022 · cited 124× · PMID 34999762 · DOI 10.1093/eurheartj/ehab914 -
Rationale and Design of the Hamburg City Health Study.
Jagodzinski A, Johansen C, Koch-Gromus U, Aarabi G, et al · · 2020 · cited 122× · PMID 31705407 · DOI 10.1007/s10654-019-00577-4 -
Association between Dietary Pattern and Periodontitis-A Cross-Sectional Study.
Altun E, Walther C, Borof K, Petersen E, et al · · 2021 · cited 58× · PMID 34836422 · DOI 10.3390/nu13114167 -
Free-water diffusion MRI detects structural alterations surrounding white matter hyperintensities in the early stage of cerebral small vessel disease.
Mayer C, Nägele FL, Petersen M, Frey BM, et al · · 2022 · cited 37× · PMID 35410517 · DOI 10.1177/0271678x221093579 -
Linking cortical atrophy to white matter hyperintensities of presumed vascular origin.
Mayer C, Frey BM, Schlemm E, Petersen M, et al · · 2021 · cited 35× · PMID 33259747 · DOI 10.1177/0271678x20974170 -
Association between periodontitis and heart failure in the general population.
Walther C, Wenzel JP, Schnabel RB, Heydecke G, et al · · 2022 · cited 18× · PMID 36101477 · DOI 10.1002/ehf2.14150 -
Kidney outcome after mild to moderate COVID-19.
Schmidt-Lauber C, Hänzelmann S, Schunk S, Petersen EL, et al · · 2023 · cited 16× · PMID 36657383 · DOI 10.1093/ndt/gfad008 -
Impact of Sex and Cardiovascular Risk Factors on Myocardial T1, Extracellular Volume Fraction, and T2 at 3 Tesla: Results From the Population-Based, Hamburg City Health Study.
Cavus E, Schneider JN, Bei der Kellen R, di Carluccio E, et al · · 2022 · cited 15× · PMID 36126126 · DOI 10.1161/circimaging.122.014158
Verify or expand the search:
- PubMed search for NCT03934957
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Coronary Heart Disease
Currently open trials in the same condition.
- NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
- NCT07230847 — A Study Evaluating the Vascular Healing and Neointimal Transformation at 1 Month After Implantation of BioFreedom™ Drug- · NA · recruiting
- NCT07110415 — Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by · Phase 4 · recruiting
- NCT07451873 — Glycocalyx and Oxidative Stress in Endothelial Function (Part 2) · recruiting
- NCT07118930 — Study of Sivelestat Sodium in OPCABG · Phase 2 · recruiting
Other Universitätsklinikum Hamburg-Eppendorf trials
Trials by the same sponsor.
- NCT07443384 — Complications Associated With Radiofrequency Microneedling in Dermatology: a Delphi Consensus · not yet recruiting
- NCT07385092 — Continuous Vital Sign Monitoring Versus Routine Spot-checks in Patients After Non-cardiac Surgery · NA · recruiting
- NCT07009522 — Hamburg Emotion Awareness and Regulation Group Training for Autistic Adolescents (HEART) · EARLY_PHASE1 · not yet recruiting
- NCT07115394 — EEG Measurements to Capture DBS-induced Electric Potentials · recruiting
- NCT06955884 — Patient Experience of Transoral Versus Transnasal Awake Tracheal Intubation · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03934957 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universitätsklinikum Hamburg-Eppendorf
- Last refreshed: 2 May 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03934957.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing